PHP96 Chronic Patients’ Perceptions About Generic Medicines in Greece: Findings from a Cross Sectional Survey  by Mylona, K. et al.
 VA L U E  I N  H E A LT H  1 6  ( 2 0 1 3 )  A 3 2 3 – A 6 3 6  A469
by the government budget. Results: Sixty-two DRGs were identified as suitable for 
day cases. The majority of these were procedures of the eye (16%), the ear, nose and 
throat (11.3%), the myoskeletal system (9.7%), the kidney and the urinary tract (9.7%) 
and the female reproductive system (9.7%). The hospital marginal cost of an increase 
in the length of stay by one day was estimated at 563.32 euros (95%CI: 541.6–585.1). 
The annual savings were estimated at 93.7 million euros for the SI and when labor 
opportunity cost is included the amount saved exceeds 225 million. ConClusions: 
In light of the economic crisis and the continuously reduced health care budget, 
the health system should adopt cost-effective intervention in order to preserve a 
satisfactory level of health services output. As this study concludes, day surgery can 
save a great amount of resources and according to the international literature can 
also guarantee patients’ safety and satisfaction.
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objeCtives: The Greek authorities implemented mandatory generic substitution 
trying to expand the use of generics, due to reasons of cost-containment. However, 
Greece lacks a strong, established generics culture. This study aims to investigate 
chronic patients’ perceptions on generics in Greece. Methods: We carried out 
a cross-sectional study among 1600 patients from four chronic illness groups 
(HTN, Diabetes, COPD and Alzheimer mild to moderate stage). Logistic regression 
analysis was used to determine the factors associated with chronic patients’ per-
ceptions. Results: Of 1600 patients, 1594 responded to the survey (99.6%). Only 
67% has used generics in the past. 39.3% considers them safe, 34.3% thinks that 
the generics have the same quality standards as the originals and 37.3% believes 
that they have the same treatment outcomes. 63% expressed concern on potential 
adverse effects from generics. 58% argues that the drug’s country of origin affects its 
safety. Statistical analysis revealed that generics quality has a statistical significant 
relationship with patient’s income (OR 1.24; 95% CI 1.00-1.19), age (OR 0.99; 95% CI 
0.98-1.00), gender (OR 0.73; 95% CI 0.57-0.94) and health status (OR 1.00; 95% CI 1.00-
1.02) while generics effectiveness was positively related with the patient’s income 
(OR 1.10; 95% CI 1.02-1.20), gender (OR 0.70, 95% CI 0.55-0.90) and health (OR 1.00, 
95% CI 1.00-1.01). Women and the elderly are less likely to consider that the gener-
ics have the same standards as the originals. ConClusions: Our findings reveal 
that chronic patients express reservations towards generic medicines which in an 
extent can probably explain the low generic market share in Greece. Perceptions 
about generics were found significant related mostly with patients’ demographic 
characteristic. The latter can be considered as useful information as it assists stake-
holders to identify on which chronic patients groups should direct campaigns in 
order to encourage generic drug use as a means to control expenditures and to save 
resources for innovative drugs.
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objeCtives: To provide an overview of the Spanish generic medicines retail market 
and to identify policy measures which impede its development. Finally, recommen-
dations to increase both the efficiency of health care with regards to pharmaceuti-
cals in general and the sustainability of the Spanish generic medicines retail market 
are put forwards. Methods: A literature review has been carried out to explore the 
current situation of the Spanish generic medicines market. In addition, a survey 
has been developed and interviews have been conducted to validate the infor-
mation obtained from the literature review. Results: The Spanish government’s 
focus on the price level of generic medicines in the past has decreased prices of 
generic medicines drastically. The current reference pricing system (since 2011) has 
eroded price differentials between originator and generic medicines in more than 
90% of the reference groups. Differing policies at the demand-side have resulted 
in differing generic market shares between the autonomous communities. Policies 
are needed to increase both the efficiency of the health care system with regards 
to pharmaceuticals (e.g. electronic prescribing, prescribing by international non-
proprietary name, etc.) and the sustainability of the Spanish generic medicines retail 
market (e.g. creating price difference between originator and generic medicines, 
accelerating market entrance, building and improving trust for generic medicines 
in patients and physicians, etc.). ConClusions: The low volume of generic medi-
cines used in Spain combined with the continuous pressure on the price level of 
generic medicines threatens the sustainability of the generic medicines industry. 
The reduced price difference between originator and generic medicines tends to 
be an important barrier for the development of a generic medicines market. The 
unique experience in the Spanish market shows the importance of demand-side 
policies on the use of generic medicines.
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objeCtives: When there are no direct head-to-head trials versus an appropriate 
comparator, indirect comparisons are commonly performed to support a clinical 
claim and relative pricing. In Australia, Public Summary Documents (PSDs), report-
ing on the Pharmaceutical Benefits Advisory Committee’s (PBAC) decision-making 
process relating to government reimbursement of medicines, have been published 
since July 2005. A review of PSDs specific to drugs where the primary claim was 
based on indirect evidence was undertaken to assess the success of the approach and 
mote its use. The audience includes those who develop, submit or use budget impact 
models and committees who evaluate reimbursement submissions. With a use 
of Guidelines for Pharmacoeconomic Evaluations, ISPOR Guidelines and proposed 
BIA template (which will be published in the updated version of the Guidelines for 
Pharmacoeconomic Evaluations) the quality of submissions to the HIF in Serbia 
would be raised and the decision time could be reduced.
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objeCtives: The recent economic crisis has threatened the sustainability of many 
international economies as well as their health care systems. The objective of this 
paper was to quantify recent cost containment measures used to reduce Irish pub-
lic pharmaceutical expenditure in light of the ongoing fiscal restrain. Methods: 
Pharmaceutical expenditure across the EU was briefly examined using the most 
current OECD data. The main pharmaceutical cost containment measures recently 
adopted in Ireland were identified under the headings of drug prices, fees/mark-ups 
and coverage/co-payments with full year 2011 public savings estimated. Results: 
EU pharmaceutical expenditure was estimated at € 190 billion in 2010, almost one 
fifth of all health expenditure. At € 528, Ireland spent more on pharmaceuticals 
than any other European country on a per capita basis and 50% more than the 
average across EU member states. Governments under pressure to maintain a sus-
tainable national health system and reduce deficits, while still preserving acute 
care levels, are cutting pharmaceutical expenditure. Many European countries, 
including Ireland, have increased the use of cost containment measures including 
a mix of price and volume controls. Collectively, these measures were estimated 
to have reduced Irish public pharmaceutical expenditure by € 380m in 2011. The 
main cost containment measures used involved addressing; 1) the ex-factory price 
of drugs including price cuts of up to 40% on off-patent and generic drugs leading 
to an estimated € 200m saving, 2) pharmacy dispensing fees and mark-ups via a 
new dispensing fee structure and reducing both retail and wholesale mark-ups 
with a € 100m saving, and 3) scheme coverage and patient co-payments including 
restricting scheme coverage for persons over 70 years and increasing the level of 
co-payments with savings of € 80m. ConClusions: There use of pharmaceutical 
cost containment measures to decrease health expenditure is a trend that is likely 
to continue for some time yet.
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objeCtives: Japan is now confronting budget constraints and trying to introduce 
economic evaluation into health care resource allocation. To clarify the basic atti-
tude towards health care resource allocation in Japanese people, a national survey 
was conducted. Methods: A survey was carried out in a face-to-face manner with 
random sampling on the 50 municipalities in Japan, adjusting for age and sex, 
between March and April 2013. The questionnaire consisted of two scenarios; ques-
tion 1:”Imagine that there are two clinical examinations (A: less expensive with 
low power; B: more expensive with high power) and choose from the following two 
options: option 1: all subjects receive examination A and subsequently the death of 
1,000 people is prevented; option 2: a half of the subjects is selected by lottery and 
receives examination B, preventing the death of 1,100 people as a consequence.” ; 
question 2:” Imagine that two types of diseases differing the treatment cost(A: 10 
million per patient; B: 2 million per patient), and allocate 100 million yens to these 
diseases.” Results: Out of 1143 respondents, 601 chose the option 1 in question 1. 
In question 2, 217 chose the least utilitarian combination(A;8, B;10), 139 chose 2nd 
combination(A;6, B;20), 289 chose 3rd one(A;4, B;30), 67 chose 4th one(A;2, B;40), and 
379 chose the most utilitarian option(A;0, B;50). The weak correlation was observed 
in the utilitarian trend and age (r= 0.29, p < 0.01). Utilitarian tendency to maximize 
the health benefit varied among respondents with different educational back-
grounds. ConClusions: We investigated the basic attitude towards health care 
resource allocation in Japanese people by answering to specific scenarios, which 
revealed fairly extreme utilitarian selection was the most popular. This utilitarian 
tendency correlated with age and education. It seems that the discussion on the 
priority setting in health care resource allocation in Japan based on this kind of 
empirical data become important.
PHP95
resourCes saved by tHe introduCtion oF day surGery in tHe Greek 
national HealtH systeM
Skroumpelos A.1, Mylona K.1, Naoum P.1, Kyriopoulos D.1, Oikonomidou R.2, Thireos E.3,  
Pavi E.1
1National School of Public Health, Athens, Greece, 2Health Center Kallikrateia, Thessaloniki, 
Greece, 3Greek NHS, Athens, Greece
objeCtives: Day surgery has been introduced in numerous heath care systems and 
has been proved able to save resources and promote efficiency and effectiveness. 
The aim of this study is to estimate the savings that can be realized by the adoption 
of day surgery by the Greek National Health System. Methods: Surgery procedures 
were classified according to the type of anesthesia and the post-operative care they 
require. The procedures identified as suitable for day surgery, according to the above 
criteria, were matched to the Greek Diagnostics Related Groups (DRGs). The possible 
savings were calculated on the basis of the marginal cost these procedures impose 
to hospitals when treating them as inpatient surgeries. Savings were estimated for 
both the social insurance(SI) and for the government budget due to the fact that SI 
reimburses the capital production factor of each DRG while the labor cost is funded 
